Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lucid Diagnostics (LUCD) Total Liabilities (2022 - 2025)

Historic Total Liabilities for Lucid Diagnostics (LUCD) over the last 4 years, with Q3 2025 value amounting to $27.4 million.

  • Lucid Diagnostics' Total Liabilities rose 6828.41% to $27.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.4 million, marking a year-over-year increase of 6828.41%. This contributed to the annual value of $25.3 million for FY2024, which is 1439.1% down from last year.
  • Per Lucid Diagnostics' latest filing, its Total Liabilities stood at $27.4 million for Q3 2025, which was up 6828.41% from $30.8 million recorded in Q2 2025.
  • In the past 5 years, Lucid Diagnostics' Total Liabilities registered a high of $38.2 million during Q1 2025, and its lowest value of $9.2 million during Q2 2022.
  • Its 4-year average for Total Liabilities is $22.2 million, with a median of $24.2 million in 2023.
  • As far as peak fluctuations go, Lucid Diagnostics' Total Liabilities skyrocketed by 21262.95% in 2023, and later crashed by 4701.51% in 2024.
  • Lucid Diagnostics' Total Liabilities (Quarter) stood at $9.5 million in 2022, then skyrocketed by 212.63% to $29.6 million in 2023, then decreased by 14.39% to $25.3 million in 2024, then increased by 8.05% to $27.4 million in 2025.
  • Its Total Liabilities was $27.4 million in Q3 2025, compared to $30.8 million in Q2 2025 and $38.2 million in Q1 2025.